Evidence for the presence of two tumour-suppressor genes for hepatocellular carcinoma on chromosome 13q - PubMed (original) (raw)
Evidence for the presence of two tumour-suppressor genes for hepatocellular carcinoma on chromosome 13q
T Kuroki et al. Br J Cancer. 1995 Aug.
Free PMC article
Abstract
The concept that genetic changes accumulate during development and progression of cancer is widely accepted. Frequent allelic losses at chromosome 13q have been found in hepatocellular carcinomas (HCCs), and a known tumour-suppressor at 13q14, the retinoblastoma (RB) gene, is thought to be the target of those events. However, no strong evidence has emerged to support a significant role of RB during hepatocarcinogenesis. To investigate the minimal area(s) of loss on chromosome 13q in HCCs, we analysed DNAs isolated from 92 tumours for loss of heterozygosity (LOH) at 13 loci on chromosome 13q, using polymorphic microsatellite markers. In 30 (32.6%) of 92 cases we detected LOH for at least one locus on chromosome 13q and 20 revealed a partial or interstitial deletion of chromosome 13q. Deletion mapping of these 20 tumours indicated two separate commonly deleted regions: one was located in the region including RB and the other was located in the region including the BRCA2 locus. These findings suggest that at least one putative tumour-suppressor gene for HCC other than RB, possibly BRCA2, exists on chromosome 13q.
Similar articles
- Loss of heterozygosity at chromosome 13q in hepatocellular carcinoma: identification of three independent regions.
Lin YW, Sheu JC, Liu LY, Chen CH, Lee HS, Huang GT, Wang JT, Lee PH, Lu FJ. Lin YW, et al. Eur J Cancer. 1999 Nov;35(12):1730-4. doi: 10.1016/s0959-8049(99)00205-1. Eur J Cancer. 1999. PMID: 10674021 - Mapping loss of heterozygosity at chromosome 13q: loss at 13q12-q13 is associated with breast tumour progression and poor prognosis.
Eiriksdottir G, Johannesdottir G, Ingvarsson S, Björnsdottir IB, Jonasson JG, Agnarsson BA, Hallgrimsson J, Gudmundsson J, Egilsson V, Sigurdsson H, Barkardottir RB. Eiriksdottir G, et al. Eur J Cancer. 1998 Dec;34(13):2076-81. doi: 10.1016/s0959-8049(98)00241-x. Eur J Cancer. 1998. PMID: 10070314 - Allelic loss on chromosome 13q in human prostate carcinoma.
Melamed J, Einhorn JM, Ittmann MM. Melamed J, et al. Clin Cancer Res. 1997 Oct;3(10):1867-72. Clin Cancer Res. 1997. PMID: 9815575 - [Loss of heterozygosity in hepatocellular carcinoma].
Takahashi K, Kudo J, Ishibashi H, Niho Y. Takahashi K, et al. Nihon Rinsho. 1993 Feb;51(2):370-4. Nihon Rinsho. 1993. PMID: 8096550 Review. Japanese. - Genetic alterations in prostate cancer.
Isaacs WB, Bova GS, Morton RA, Bussemakers MJ, Brooks JD, Ewing CM. Isaacs WB, et al. Cold Spring Harb Symp Quant Biol. 1994;59:653-9. doi: 10.1101/sqb.1994.059.01.075. Cold Spring Harb Symp Quant Biol. 1994. PMID: 7587126 Review.
Cited by
- Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment.
Sogbe M, Bilbao I, Marchese FP, Zazpe J, De Vito A, Pozuelo M, D'Avola D, Iñarrairaegui M, Berasain C, Arechederra M, Argemi J, Sangro B. Sogbe M, et al. Clin Mol Hepatol. 2024 Apr;30(2):177-190. doi: 10.3350/cmh.2023.0426. Epub 2023 Dec 29. Clin Mol Hepatol. 2024. PMID: 38163441 Free PMC article. - Transcriptome analysis identifies metallothionein as biomarkers to predict recurrence in hepatocellular cacinoma.
Wang S, Gribskov M. Wang S, et al. Mol Genet Genomic Med. 2019 Jun;7(6):e693. doi: 10.1002/mgg3.693. Epub 2019 May 6. Mol Genet Genomic Med. 2019. PMID: 31056863 Free PMC article. - Hepatocellular Carcinoma: Causes, Mechanism of Progression and Biomarkers.
Singh AK, Kumar R, Pandey AK. Singh AK, et al. Curr Chem Genom Transl Med. 2018 Jun 29;12:9-26. doi: 10.2174/2213988501812010009. eCollection 2018. Curr Chem Genom Transl Med. 2018. PMID: 30069430 Free PMC article. Review. - PCDH9 acts as a tumor suppressor inducing tumor cell arrest at G0/G1 phase and is frequently methylated in hepatocellular carcinoma.
Lv J, Zhu P, Zhang X, Zhang L, Chen X, Lu F, Yu Z, Liu S. Lv J, et al. Mol Med Rep. 2017 Oct;16(4):4475-4482. doi: 10.3892/mmr.2017.7193. Epub 2017 Aug 8. Mol Med Rep. 2017. PMID: 28791409 Free PMC article. - The genetic and epigenetic alterations in human hepatocellular carcinoma: a recent update.
Liu M, Jiang L, Guan XY. Liu M, et al. Protein Cell. 2014 Sep;5(9):673-91. doi: 10.1007/s13238-014-0065-9. Epub 2014 Jun 11. Protein Cell. 2014. PMID: 24916440 Free PMC article. Review.
References
- Science. 1988 Jul 8;241(4862):218-21 - PubMed
- Nat Genet. 1994 Jun;7(2 Spec No):246-339 - PubMed
- Proc Natl Acad Sci U S A. 1989 Jul;86(13):5099-103 - PubMed
- Proc Natl Acad Sci U S A. 1989 Nov;86(22):8852-6 - PubMed
- Proc Natl Acad Sci U S A. 1990 Sep;87(17):6791-4 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous